Heme Definitions and Info Flashcards
rbc appearance
no nuclei, appearing as biconcave disks filled with hemoglobin
neutrophil appearance
3-5 nuclear lobes with cytoplasm containing pale, iliac colored granules.
neutrophils
they are phagocytes and protect against acute protection
life span of neutrophils
5 hrs to a few days
basophils appearance
lack a nuclear segment
role of basophils
similar to eosinophils
eosinophils appearance and role
2 nuclear lobes and play a role in chronic immune responses particularly those associated with helminth worm infections, asthma, and allergies
what is largest wbc
monocyte
monocyte appearance
kidney shaped nuclear and light blue cytoplasm
monocyte role
similar to neutrophils and are highly phagocytic but long lived and serve as sentinels detecting danger signals produced by infection or tissue injury
what is the key component in adaptive immune system
lymphocytes
lymphocyte appearance
condensed nuclei and scant cytoplasm
what may lymphocytes be
B cells, T cells, or natural killer cells
B cells are formed where
bone marrow
T cells are made where
thymus
how many rbcs, platelets and neutrophils does the bone marrow produce every day
rbcs -> 200 billion
platelets -> 100 billion
neutrophils -> 60 billion
why is hematopoiesis highly responsive to changes in peripheral counts
bc cytopenias and cytoses blood cells have serious even fatal consequences
what is hematopoiesis maintained by
hematopoietic stem cells
what is transplanted during a stem cell transplant
hematopoietic stem cells
what does the clot formation start with
primary platelet plug
what does the activation of platelets also result in and what is it converted to
arachidonic acid which is converted to thromboxane a2
thromboxane a2
potent inducer of platelet via a series of enzymes including cyclooxygenase
what does aspirin contain
cyclooxyrgenase inhibitors which is why aspiring is used to suppress platelet activation
activation of platelets also causes it to release and activation of what
proteins that contribute to homeostasis such as platelet factor 4, fibrinogen and factor 5. activates factor xa receptor on the cell membrane of the platelet which joins with factor 5 to generate thrombin.
what does defects in coagulation or thrombolysis lead to
hypercoagulability or bleeding disorders
initial tests of blood coagulation cascade
platelet count
prothrombin time (pt)
partial thromboplastin time (ptt)
normal platelet count
> 100,000 per microliter
what happens if platelet count falls below 100,000
takes longer time to clot and usually comes with symptoms like purpura and mucosal bleeding
pt is a test of what pathway
extrinsic
what is a normal pt
10-13 secs
if pt is high what does it mean
deficiency in one or more of clotting factors in extrinsic pathway (VII, X V, prothrombin, fibrinogen).
inr is derived from what
pt
inr is the same as pt except
it is standardized by taking into account potency of tissues factor used
aptt is a test of what pathway
intrinsic
what is a normal ptt
25-35 secs
what is added to plasma which activates factor XII and starts intrinsic cascade
kaolin
intrinsic cascade
factors XII, XI, IX, VIII, X, V, prothrombin and fibrinogen.
tt
test of functionality of fibrinogen and presence of thrombin inhibitors
in inherited bleeding disorders how many deficiencies are present
single
in pts w/ acquired bleeding problem such as with liver disease or vitamin k deficiency how many deficiencies are present
multiple
labs in factor 5 & 10 or prothrombin defect
pt & ptt -prolonged
tt - normal
labs in factor 5 & 10 or prothrombin defect
pt -pronlonged
labs in factor 7 defect
pt - prolonged
ptt & tt - normal
labs in factor 12,11,9,8 defect
pt and tt- normal
ptt - prolonged
labs in fibrinogen and thrombin inhibitor
pt and ptt- normal or prolonged
tt- proloned
vitamin k antagonists
block or slow down clotting by affecting 7, 9, 10 and prothrombin bc they all need vitamin k for carboxylation
mc vit. k antagonist
warfarin
how to monitor pts on heparin and why
pt/inr testing to make sure the degree of anticoagulation is within therapeutic range
heparin
activates antithrombin and thus inhibits steps in cascade. IV.
low molecular weight heparin
sq heparin that does not require intensive monitoring but also doesn’t work as rapidly
direct inhibitors
new oral anticoagulants that directly inhibit activated coagulation factors (in contrast to warfarin, which is indirect and affects the cascade)
three defects in clotting cascade
platelet function/thrombocytopenia
decrease in clotting factors due to decreased production or excess consumption
decrease in clotting factors because inherited defect
thrombocytopenia
too few platelets due to decreased platelet production or enhanced platelet destruction
platelet life span
7-9 days
platelet survival with decreased production
a week before severe thrombocytopenia occurred
platelet survival with destruction
curtails platelet survival suddenly and swiftly and can produce severe thrombocytopenia within hours
what does splenomegaly entail
high portion of platelets entrapped in spleen along with red and white blood cells
hypersplenism
reduction in one or more peripheral blood counts by splenic sequestration
platelet count of 50,000 to 120,00 which is not low enough to poser serious risk of hemorrhage
hypersplenidism
immune thrombocytoenic purpura (ITP)
immune mediated isolated thrombocytopenia caused by autoantibodies against platelets which leads to destruction of platelets
primary ITP
idiopathic, MC after viral infection
secondary ITP
immune mediated but associated w/ underlying disorders such as SLE, HIV, HCV
heparin induced thrombocytopenia
acquired within first 5-10 after initiation of heparin caused by autoantibody formation to the hapten of heparin & platelet factor which cause platelet activation and consumption leading to simultaneous thrombocytopenia and thrombosis.
disseminated intravascular coagulation (DIC)
activation of coagulation system leads to uncontrolled fibrin production due to tissue factor activation leading to widespread microthrombi which consumes coagulation proteins & platelets.
disseminated intravascular coagulation (DIC) etiologies
obstetric
infections (MC is gram negative sepsis)
malignancies (acute myelogenous leukemia, lung, GI or prostate malignancies)
what are bleeding disorders caused by
decrease in clotting factors due to decreased production or excess consumption
MCC of bleeding disorders
vitamin k deficiency/anticoagulation therapy
coagulopathy associated with liver disease
DIC can be considered excess consumption of clotting factors
what does vit k deficiency lead to
decrease in coagulation factors 2, 7, 9, 10 and the coagulation regulators protein c and s.
what is responsible for the carboxylation of factors 2, 7, 9, 10
vitamin k
what interferes with activation of vitamin k
warfarin
role of the liver
production and metabolism of coagulation factors
what can severe liver failure result in
bleeding tendency bc of factor deficiency
which factor is preserved in liver disease and where is it produced
factor 8 and in the endothelium
bleeding disorders caused by a decrease in clotting factors due to an inherited effect
hemophilia A & B
Von Willebrand Disease
hemophilia a
inherited blood disorder most often associated with severe morbidity frequently requiring hospitalization
hemophilia a is due to deficiency of what factor
8
what kind of disorder is hemophilia a
x linked recessive
what % of pts have no family history and hemophilia a is due to spontaneous mutations
30%
hemophilia occurs in how male births
1/5000
pts w/ 1% or less factor 8 are considered what
severe and have average of 20-30 episodes per year of either spontaneous bleeding or excessive bleeding after minor trauma
if pt w/ 1-4% factor 8 they’re considered
to have moderate hemophilia
if pt w/ 4% ir more factor 8 considered to have
mild hemophilia and generally have bleeding episodes only after trauma or surgery
hemophilia a life expectancy
60 yrs
leading cause of death among adult hemophilia pts
aids
hemophilia b
inherited bleeding disorder similar genetic, clinical, and molecular factors as hemophilia a
hemophilia b due to deficiency in
factor 9
where is the gene for factor 9 located and how im hemophilia b inherited
on X chromosome and inherited in x linked manner w/ female heterozygous carries passing the disease to half of sons
hemophilia b occurs in how many males
1/25000-30000
MC inherited bleeding disorder
von willebrand disease
von willebrand disease effects how many people
1/90 in US or 3 billion
how is von willebrand disease different from hemophilias
- it is inherited is autosomal dominant way
- bleeding is primarily from mm
- bleeding time is prolonged
von willebrand disease caused by
mutations in the gene encoding von willebrand factor
functions of von willebrand factor protein
- chaperones factor 8 protecting it from degradation
2. acts as molecular glue that enables platelets to adhere to injured blood vessels
what people have lower levels of plasma vWF and are commonly diagnosed a having von willebrand disease
humans with group O blood
type 1 von willebrand disease
vWF protein deficiencies and mc form (70%)
type 2 von willebrand disease
protein defects (not deficiencies) and accounts for 25% of cases
type 3 von willebrand disease
inherited a mutant vWF gene from each parent and proteins are very low so these pts have much more severe bleeding problems
thrombophilia
lab abnml that increase rick of venous thromboembolism and pts w/ hx of recurrent VTE, VTE at young age, strong fam hx of VTE or thrombosis at unusual site
virchows triad
abnml blood flow (stasis)
vessel injury or inflammation
hypercoagulability
common cause of acquired thrombophilia
antiphospholipid syndrome
acquired causes of thrombophilia
transient thrombophilia, including taking estrogen based contraception, pregnancy, cancer, surgery and immobilization
mc hereditary cause of thrombophilia
factor V leiden mutations and deficient of natural anticoagulants antithrombin, protein c, and protein s
about 1/2 of pts with hereditary thrombophilia have first thrombotic episode in relation to what
acquired prothrombotic risk factor
mc inherited cause of hyper coagulability
factor v leiden mutation
how much % of population effected by factor v leiden mutation
5%
factor v leiden mutation
genetic variant that increases activity of factor v bc it is resistant to breakdown by activated protein c
protein c or s deficiency
loss of function mutations that interfere w/ activity of inhibitors of coagulation rather than increasing activity if procoagulant factors.
protein c and s are … dependent and produced in the …
vit k, liver
anemia
lack of healthy rbcs or hemoglobin
causes of anemia
Hypoproliferative = Decreased production of RBCs or their components Maturation = Inability of components to produce a healthy RBC or hemoglobin, often due to structural abnormality or deficiency of precursors Hemolytic = destruction of RBCs or their components